Lanthanide-Enhancers in the Radiotherapy of Cancer
In Germany alone every year about 400.000 people develop cancer. The radiation ther-apy is widely used as a method of treat-ment. Cancer cells will be harmed more, because they are more sensitive than healthy cells to ionizing radiation. Neverthe-less to reduce the cancer cell growth, sig-nificantly high doses of radiation have to be used. But this leads to unwanted side-effects. Locally acting enhancers can in-crease the radiation, so that the cumulative dose is reduced and at the same time the ionizing effect in the tumor tissue itself is increased. Furthermore the radiation en-hancer should not be toxic for the healthy tissue.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50
Contact
Dr. Klaus Kobek
Media Contact
All latest news from the category: Technology Offerings
Newest articles
‘Entirely unanticipated’ role of protein netrin1 in spinal cord development
Known for its axon guidance properties, new research suggests protein is critical in guiding neural development. Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research…
AI to improve brain cancer diagnosis, monitoring, treatment
Recommendations published in The Lancet Oncology call for good clinical practice of new technologies to modernize decades-old standard of care for brain cancer patients. An international, multidisciplinary team of leading…
AI tool ‘sees’ cancer gene signatures in biopsy images
AI tool reads biopsy images… To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a microscope. But to figure out…